# Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease

> **NCT06805266** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Marianna Amboni** · enrollment: 40 (estimated)

## Conditions studied

- Parkinson Disease, Idiopathic
- Freezing of Gait
- Depression Not Otherwise Specified

## Interventions

- **DRUG:** Vortioxetine (tablet)

## Key facts

- **NCT ID:** NCT06805266
- **Lead sponsor:** Marianna Amboni
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06805266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06805266, "Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06805266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*